CytomX Therapeutics Inc.
06/22/2026 | Press release | Distributed by Public on 06/22/2026 14:52
Amendments to Bylaws (Form 8-K)
| Item 5.03. |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
On June 22, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company's Amended and Restated Certificate of Incorporation to increase the authorized number of shares of the Company's common stock from 300,000,000 to 600,000,000 shares (the "Charter Amendment"). The Charter Amendment was approved by the Company's stockholders at the Annual Meeting on June 17, 2026.
The foregoing description of the Charter Amendment does not purport to be complete and is qualified in its entirety by reference to the complete text thereof, which is filed as Exhibit 3.1 and incorporated herein by reference.
CytomX Therapeutics Inc. published this content on June 22, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 22, 2026 at 20:53 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]